Friday, 31 Oct 2025
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA
logo logo
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
  • 🔥
  • Trump
  • VIDEO
  • House
  • White
  • ScienceAlert
  • Trumps
  • Watch
  • man
  • Health
  • Season
Font ResizerAa
American FocusAmerican Focus
Search
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
Follow US
© 2024 americanfocus.online – All Rights Reserved.
American Focus > Blog > Health and Wellness > 340B Legal Challenges Highlight The Appetite For Innovation
Health and Wellness

340B Legal Challenges Highlight The Appetite For Innovation

Last updated: November 22, 2024 8:42 am
Share
340B Legal Challenges Highlight The Appetite For Innovation
SHARE

A recent development in the healthcare industry has caught the attention of many stakeholders. On November 12, 2024, Johnson & Johnson made a bold move by filing a lawsuit against the Health Resources and Services Administration (HRSA) regarding the 340B Drug Pricing Program. This action was taken following a dispute over J&J’s plan to modify how it handles cost discounts for 340B purchases. The changes proposed by J&J and the response from HRSA shed light on the complexities within the program, with far-reaching implications for patients, hospitals, and drug manufacturers. It also underscores the pressing need for reforms in the administration of the 340B program.

The 340B program has faced criticism in the past due to a lack of transparency regarding the entities receiving discounts from drug manufacturers. This lack of oversight has raised concerns about potential abuse of the program. Recognizing these issues, J&J, along with other drug makers, devised a plan to address these challenges.

On August 23, 2024, J&J announced a new rebate model for two of its drugs, Stelara and Xarelto, specifically for Disproportionate Share Hospitals (DSH CEs). This model aimed to change the method of delivering discounts without affecting eligibility or the amount of the discount.

In response, HRSA issued warnings to J&J on September 17 and September 27, stating that the proposed rebate model had not received approval from the HHS Secretary. They threatened severe penalties, including the termination of J&J’s participation in 340B, Medicaid, and Medicare. Consequently, J&J decided to suspend the implementation of the rebate model in October and later filed a lawsuit against HRSA.

See also  Noxtua raises $92M for its sovereign AI tuned for the German legal system

At the core of the lawsuit is the interpretation of the 340B statute, which does not dictate the specific delivery of discounts, leaving it to the discretion of the manufacturer. J&J’s objective in the lawsuit is to be allowed to implement their rebate model without facing the sanctions threatened by HRSA. The need for improved data, transparency, and eligible drug rebates to benefit disadvantaged patients is highlighted in this context.

An analysis of J&J’s proposed rebate model reveals potential benefits, such as enhanced transparency, real-time data access, and compliance with the Inflation Reduction Act’s Maximum Fair Price. While J&J’s approach has its merits, it has faced criticism from organizations like the American Hospital Association (AHA), which deemed the lawsuit “completely meritless.” Alternative models, like Eli Lilly’s cash replenishment model, are also emerging to streamline the discount process and enhance transparency.

These innovative models offer viable alternatives to the current 340B processes, prompting legislators to consider reforms. The recent Supreme Court ruling overturning the Chevron doctrine may influence the future direction of the 340B program by emphasizing statutory alignment and intent. Ultimately, comprehensive changes are needed in healthcare funding, but these proposals offer valuable insights into addressing existing flaws in the 340B program.

TAGGED:340BAppetitechallengesHighlightInnovationlegal
Share This Article
Twitter Email Copy Link Print
Previous Article VersaClimbers, Tiger Woods and Houston’s plan to get Kelvin Sampson a championship VersaClimbers, Tiger Woods and Houston’s plan to get Kelvin Sampson a championship
Next Article Cher Reveals Val Kilmer Is One of the Only Men Who Ever Broke Up With Her Cher Reveals Val Kilmer Is One of the Only Men Who Ever Broke Up With Her
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Popular Posts

Victor Reacts: Attacks on ICE: The Left Got Their Wish (VIDEO) |

For years, critics on the left have warned that the Trump administration was constructing something…

July 9, 2025

Before You Buy That ‘Cheap’ Stock, Read the Proxy, Not The Pitch Deck

Capital Allocation: The Hidden Cost Of Ego When delving deeper into the inner workings of…

July 6, 2025

UK DYSTOPIA: Former Soccer Star Gary Lineker Gets Canceled, Fired From the BBC and May Face Police Investigation Over Allegedly Anti-Semitic Post |

Gary Lineker’s opinions on the Gaza conflict have landed him in troubled waters. In a…

May 21, 2025

Walt Disney Animation Studios FĂŞtes Female Animation Talent at Animayo

Walt Disney Animation Studios is honoring the incredible female talent in art and animation with…

April 27, 2025

Top 7 Fall Shoe Trends In 2024 You Need to Know

These shoes offer a unique blend of comfort and edge, making them a versatile option…

October 15, 2024

You Might Also Like

As Medicaid work requirements loom, study finds links between coverage, better health and higher employment
Health and Wellness

As Medicaid work requirements loom, study finds links between coverage, better health and higher employment

October 31, 2025
Digital Twins Coming To Robotic Surgery
Health and Wellness

Digital Twins Coming To Robotic Surgery

October 31, 2025
Medicare, midterm elections, Vinay Prasad: Morning Rounds
Health and Wellness

Medicare, midterm elections, Vinay Prasad: Morning Rounds

October 31, 2025
Remission achievable for 1 in 3 Indian diabetics through intensive app-based lifestyle program, study suggests
Health and Wellness

Remission achievable for 1 in 3 Indian diabetics through intensive app-based lifestyle program, study suggests

October 31, 2025
logo logo
Facebook Twitter Youtube

About US


Explore global affairs, political insights, and linguistic origins. Stay informed with our comprehensive coverage of world news, politics, and Lifestyle.

Top Categories
  • Crime
  • Environment
  • Sports
  • Tech and Science
Usefull Links
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA

© 2024 americanfocus.online –  All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?